Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-Resistant Enterococcus: Infectious Endocarditis Treatment.

Rybak1, Coyle

  • 1The Anti-Infective Research Laboratory, Department of Pharmacy Services, Detroit Receiving Hospital and University Health Center, 4201 St. Antoine Blvd, Detroit, MI 48201, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In memoriam

Harvard review of psychiatry·2000
Same author

Chronic Meningitis.

Current treatment options in neurology·2000
Same author

Serologic testing for lyme disease

JAMA·2000
Same author

Laser ultrasonic surface wave inspection of alumina ceramics of varying density

Ultrasonics·2000
Same author

Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat.

Pathophysiology : the official journal of the International Society for Pathophysiology·2000
Same author

Experimental topical ototoxicity investigations: can we underestimate unilateral ototoxicity because of cross-hearing?

Otolaryngology and head and neck surgery·2000
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Vancomycin-resistant Enterococcus infections are a serious threat with limited treatment options. New antibiotics like daptomycin show promise for endocarditis, but more research, especially on combination therapies, is crucial.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Vancomycin-resistant Enterococcus (VRE) species are critical gram-positive pathogens.
  • Currently, no definitive therapy is recommended for VRE infections.
  • Emerging antibiotic resistance necessitates novel treatment strategies.

Purpose of the Study:

  • To review the current landscape of antibiotics for VRE infections.
  • To evaluate the potential of new antimicrobial agents for treating VRE endocarditis.
  • To highlight the need for further research into combination therapies.

Main Methods:

  • Review of existing literature on VRE treatment.
  • Analysis of preclinical (animal) and clinical data for novel agents.
  • Assessment of antibiotic efficacy for various VRE infection types.

Related Experiment Videos

Main Results:

  • New agents including quinupristin-dalfopristin, LY333328, and daptomycin demonstrate activity against VRE.
  • Limited data suggest potential utility of these agents for VRE endocarditis.
  • Experience with these agents is extensive for other infections but limited for endocarditis.

Conclusions:

  • Quinupristin-dalfopristin, LY333328, and daptomycin may offer therapeutic options for VRE endocarditis.
  • Further investigation is required to establish optimal treatment regimens.
  • Combination therapies are essential to enhance efficacy and mitigate resistance development.